Prodromal dementia with lewy bodies manifesting as sertraline-induced parkinsonism: A case report

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 2, 2012, Pages 191-193

  Kim, Jin Hyuck ^a   Park, Jaeseol ^b   Yu, Kyung Ho ^b   Ma, Hyeo Il ^b   Lee, Byung Chul ^b   Kim, Imyel ^d   Kim, Yun Joong ^b,c  

^a Keyo Medical Foundation   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

^d Keyo Medical Foundation   (South Korea)

Author keywords

dementia with Lewy bodies; drug induced parkinsonism; sertraline

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DONEPEZIL; SERTRALINE;

AGED; ARTICLE; BRADYKINESIA; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CASE REPORT; CATALEPSY; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE EXACERBATION; DRUG INDUCED DISEASE; DRUG INDUCED PARKINSONISM; DRUG WITHDRAWAL; EXECUTIVE FUNCTION; FLUENCY DISORDER; FOLLOW UP; GAIT DISORDER; HEART SCINTISCANNING; HOSPITAL READMISSION; HUMAN; MALE; MEDICAL HISTORY; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NIGHTMARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PERSECUTORY DELUSION; PRIORITY JOURNAL; SOMNOLENCE; UNIFIED PARKINSON DISEASE RATING SCALE; UNSTEADINESS; URINE INCONTINENCE; VERBAL MEMORY; VISUAL HALLUCINATION; VISUAL MEMORY; WALKING AID; WALKING DIFFICULTY; WHEELCHAIR; WHITE MATTER LESION;

AGED; ANXIETY; DEMENTIA; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; LEWY BODIES; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; SERTRALINE;

EID: 84861456938     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318231a896     Document Type: Article

References (17)

1. McKeith IG., Dickson DW., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872. (Pubitemid 43970103)
2. Wenning GK., Kiechl S., Seppi K., et al. Prevalence of movement disorders in men and women aged 50 to 89 years (Bruneck study cohort): a population-based study. Lancet Neurol. 2005;4:815-820. (Pubitemid 41619436)
3. Micheli FE., Cersó simo MG. Drug-induced parkinsonism. Handb Clin Neurol. 2007;84:399-416.
4. Mena M.A., de Yebenes JG. Drug-induced parkinsonism. Expert Opin Drug Saf. 2006;5:759-771. (Pubitemid 44669491)
5. Ma HI., Kim JH., Chu MK., et al. Diabetes mellitus and druginduced Parkinsonism: a case-control study. J Neurol Sci. 2009;284:140-143.
6. Tolosa E., Gaig C., Santamaria J., et al. The premotor phase of Parkinson disease. Parkinsonism Relat Disord. 2007; 13(suppl 1):S2-S7.
7. Marek K., Jennings D Can we image premotor Parkinson disease? Neurology. 2009 72 (suppl 2) S21-S26.
8. Gasser T. Genomic and proteomic biomarkers for Parkinson disease. Neurology. 2009;72(suppl 2):S27-S31.
9. Petersen RC., Roberts RO., Knopman DS., et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447-1455.
10. Draper B., Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging. 2008;25:501-519. (Pubitemid 351812258)
11. Schillevoort I., van Puijenbroek EP., de Boer A., et al. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol. 2002;17:75-79. (Pubitemid 34169650)
12. Gerber PE., Lynd LD. Selective serotonin-reuptake inhibitorinduced movement disorders. Ann Pharmacother. 1998;32: 692-698.
13. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry. 1996;57:449-454. (Pubitemid 26362308)
14. Pina Latorre M.A., Modrego PJ., Rodilla F., et al. Parkinsonism and Parkinson's disease associated with long-term administration of sertraline. J Clin Pharm Ther. 2001;26:111-112. (Pubitemid 32336726)
15. Gregory RJ., White JF Can sertraline induce parkinson's disease? Psychosomatics. 2001 42 163-164. (Pubitemid 32180008)
16. Di Rocco A., Brannan T., Prikhojan A., et al. Sertraline induced parkinsonism: a case report and an in-vivo study of the effect of sertraline on dopamine metabolism. J Neural Transm. 1998;105:247-251. (Pubitemid 28243231)
17. Tolosa E., Coelho M., Gallardo M. DAT imaging in druginduced and psychogenic parkinsonism. Mov Disord. 2003; 18(suppl 7):S28-S33. (Pubitemid 37336925)